Nessan Bermingham
2016
In 2016, Nessan Bermingham earned a total compensation of $4M as President and Chief Executive Officer at Intellia Therapeutics, a 613% increase compared to previous year.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Option Awards | $3,338,330 |
| Salary | $450,000 |
| Other | $718 |
| Total | $4,014,048 |
Bermingham received $3.3M in option awards, accounting for 83% of the total pay in 2016.
Bermingham also received $225K in bonus, $450K in salary and $718 in other compensation.
Rankings
In 2016, Nessan Bermingham's compensation ranked 2,224th out of 14,075 executives tracked by ExecPay. In other words, Bermingham earned more than 84.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,224 out of 14,075 | 84th |
Division Manufacturing | 774 out of 5,489 | 86th |
Major group Chemicals And Allied Products | 225 out of 1,895 | 88th |
Industry group Drugs | 163 out of 1,538 | 89th |
Industry In Vitro and In Vivo Diagnostic Substances | 4 out of 65 | 94th |
Source: SEC filing on April 18, 2017.
Bermingham's colleagues
We found two more compensation records of executives who worked with Nessan Bermingham at Intellia Therapeutics in 2016.